Kidney

Clinical practice guidelines for the assessment of potential kidney transplant recipients cover access to renal transplantation and the evaluation, and selection and preparation of potential transplant recipients (Dudley and Harden, 2011). Nine recommendations for the pre-transplant assessment, evaluation, selection and screening of potential renal transplantation recipients are provided. These include guidelines for patients with cancer and prior testing for viral infections (Dudley and Harden, 2011).

  • Potential recipients of renal transplantation with previous malignancy (excluding non-melanoma skin cancer) should only be considered if there is no evidence of persistent cancer. The recommended waiting time between successful tumour treatment/remission and transplantation should be at least 2 years, and extended to longer than 5 years for some malignancies (Dudley and Harden, 2011).
  • Potential recipients should undergo testing for cytomegalovirus (CMV), Epstein-Barr virus (EBV), varicella zoster virus (VZV), hepatitis B and C and human immunodeficiency virus (HIV) (Dudley and Harden, 2011).

A review of international guidelines published between 2001 and 2011 for patients on waiting lists for kidney transplantation identified some inconsistencies between guidelines regarding eligibility criteria (Batabyal et al., 2012).

European Renal Best Practice Guidelines on evaluation of kidney donors and recipients, and perioperative care have recently been published (Abramowicz et al., 2015).

The British Transplantation Society has developed guidelines for kidney and/or pancreas transplantation in patients with HIV (British Transplantation Society, 2015).